ADMA BIOLOGICS INC's ticker is ADMA and the CUSIP is 000899104. A total of 251 filers reported holding ADMA BIOLOGICS INC in Q2 2024. The put-call ratio across all filers is 0.04 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $114,715 | +67.9% | 10,304 | -0.5% | 0.00% | +50.0% |
| Q1 2024 | $68,343 | +46.0% | 10,355 | 0.0% | 0.00% | +100.0% |
| Q4 2023 | $46,805 | +25.0% | 10,355 | -1.0% | 0.00% | 0.0% |
| Q3 2023 | $37,440 | -7.9% | 10,458 | -5.1% | 0.00% | 0.0% |
| Q2 2023 | $40,671 | +8.1% | 11,022 | -3.0% | 0.00% | 0.0% |
| Q1 2023 | $37,608 | – | 11,362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 883,214 | $1,722,000 | 0.80% |
| Telemetry Investments, L.L.C. | 200,615 | $391,000 | 0.66% |
| Perceptive Advisors | 16,584,802 | $32,340,000 | 0.35% |
| Consonance Capital Management LP | 1,558,290 | $3,039,000 | 0.28% |
| 683 Capital Management, LLC | 2,000,000 | $3,900,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 627,931 | $1,224,000 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 327,052 | $638,000 | 0.10% |
| APOGEM CAPITAL LLC | 54,240 | $106,000 | 0.07% |
| HUSSMAN STRATEGIC ADVISORS, INC. | 82,000 | $160,000 | 0.04% |
| J. Goldman & Co LP | 376,319 | $734,000 | 0.04% |